Ionomycin activates p38 and p42/44 MAP kinases (MAPK) in human neutrophils (PMNS).

被引：0
|
作者：
Elzi, D
Silliman, C
机构：
[1] Univ Colorado, Sch Med, Denver, CO 80220 USA
[2] Bonfis Blood Ctr, Denver, CO 80220 USA
来源：
JOURNAL OF INVESTIGATIVE MEDICINE | 1999年 / 47卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：188A / 188A
页数：1
相关论文
共 50 条
  • [41] One-way cross-talk between p38MAPK and p42/44MAPK -: Inhibition of p38MAPK induces low density lipoprotein receptor expression through activation of the p42/44MAPK cascade
    Singh, RP
    Dhawan, P
    Golden, C
    Kapoor, GS
    Mehta, KD
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (28) : 19593 - 19600
  • [42] p38 and p42/44 MAPKs Differentially Regulate Progesterone Receptor A and B Isoform Stabilization
    Khan, Junaid A.
    Amazit, Larbi
    Bellance, Catherine
    Guiochon-Mantel, Anne
    Lombes, Marc
    Loosfelt, Hugues
    MOLECULAR ENDOCRINOLOGY, 2011, 25 (10) : 1710 - 1724
  • [43] Induction of COX-2 expression by R(+)-methanandamide in human neuroglioma cells involves activation of p38 and p42/44 MAPK signaling pathways
    Ramer, R
    Brune, K
    Pahl, A
    Hinz, B
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2002, 365 : R36 - R36
  • [44] Differential Modulation of the Phosphoproteome by the MAP Kinases Isoforms p38α and p38β
    Kadosh, Dganit Melamed
    Beenstock, Jonah
    Engelberg, David
    Admon, Arie
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (15)
  • [45] AN INHIBITOR OF P38 MAP KINASE ACTIVATES ERK AND JNK MAP KINASES IN PRIMARY CULTURES OF HUMAN HEPATOCYTES
    Vrzal, Radim
    Henklova, Pavla
    Papoukova, Barbora
    Bednar, Petr
    Jancova, Petra
    Anzenbacherova, Eva
    Ulrichova, Jitka
    Maurel, Patrick
    Pavek, Petr
    Dvorak, Zdenek
    DRUG METABOLISM REVIEWS, 2008, 40 : 102 - 103
  • [46] Activation of p42/p44 mitogen-activated protein kinases (MAPK) and p38 MAPK by tumor necrosis factor (TNF) is mediated through the death domain of the 55-kDa TNF receptor
    Boone, E
    Vandevoorde, V
    De Wilde, G
    Haegeman, G
    FEBS LETTERS, 1998, 441 (02) : 275 - 280
  • [47] Distinct roles of p42/p44ERK and p38 MAPK in oxidant-induced AP-1 activation and cardiomyocyte hypertrophy
    Victoria C. Tu
    Joe J. Bahl
    Qin M. Chen
    Cardiovascular Toxicology, 2003, 3 (2) : 119 - 133
  • [48] High glucose enhances cyclic strain-induced mesangial cell p44/p42 mitogen-activated protein kinase (MAPK) but not p38 MAPK
    Dlugosz, JA
    Whiteside, CI
    DIABETES, 1999, 48 : A137 - A137
  • [49] Regulation of VEGF-induced endothelial cell PAF synthesis:: role of p42/44 MAPK, p38 MAPK and PI3K pathways
    Bernatchez, PN
    Allen, BG
    Gélinas, DS
    Guillemette, G
    Sirois, MG
    BRITISH JOURNAL OF PHARMACOLOGY, 2001, 134 (06) : 1253 - 1262
  • [50] Target selectivity of MAPK phosphorothioate antisense ODN on p42/p44, p38 MAPK, and JNK protein expression and its inhibitory effect on VSMC DNA synthesis
    Huang, SL
    Ding, B
    Li, J
    Yi, FX
    Liu, WL
    Yu, QS
    Guo, ZG
    ACTA PHARMACOLOGICA SINICA, 1999, 20 (07) : 613 - 617
12345